Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

In this episode of Lessons in Leadership, Steve Adubato and Mary Gamba talk with Cecilia McKenney, SVP & Chief Human Resources Officer, Quest Diagnostics, about the keys to recruiting, training, and ...

Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Quest Diagnostics logged a -1.0% change during today's afternoon session, and is now trading at a price of $166.27 per share.

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...

Proponents herald the practice as a free-market approach to providing medical care, while critics say it could widen health ...

This was the stock's second consecutive day of losses.

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...